These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19959676)

  • 1. Abuse liability assessment of tobacco products including potential reduced exposure products.
    Carter LP; Stitzer ML; Henningfield JE; O'Connor RJ; Cummings KM; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3241-62. PubMed ID: 19959676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.
    Vansickel A; Baxter S; Sherwood N; Kong M; Campbell L
    Nicotine Tob Res; 2022 Feb; 24(3):295-305. PubMed ID: 34498698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.
    Henningfield JE; Benowitz NL; Slade J; Houston TP; Davis RM; Deitchman SD
    Tob Control; 1998; 7(3):281-93. PubMed ID: 9825424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.
    Guydish J; Tajima B; Pramod S; Le T; Gubner NR; Campbell B; Roman P
    Drug Alcohol Depend; 2016 Sep; 166():93-9. PubMed ID: 27449271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
    Pfeffer D; Wigginton B; Gartner C; Morphett K
    Nicotine Tob Res; 2018 Aug; 20(9):1038-1046. PubMed ID: 29059355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.
    Henningfield JE; Hatsukami DK; Zeller M; Peters E
    Drug Alcohol Depend; 2011 Jul; 116(1-3):1-7. PubMed ID: 21376479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products.
    Hamilton WL; Norton Gd; Ouellette TK; Rhodes WM; Kling R; Connolly GN
    Nicotine Tob Res; 2004 Dec; 6 Suppl 3():S353-62. PubMed ID: 15799598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.
    Harris AC; Tally L; Schmidt CE; Muelken P; Stepanov I; Saha S; Vogel RI; LeSage MG
    Drug Alcohol Depend; 2015 Feb; 147():60-7. PubMed ID: 25561387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Believability of Cigarette Warnings About Addiction: National Experiments of Adolescents and Adults.
    Lazard AJ; Kowitt SD; Huang LL; Noar SM; Jarman KL; Goldstein AO
    Nicotine Tob Res; 2018 Jun; 20(7):867-875. PubMed ID: 29059352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.
    Higgins ST; Heil SH; Sigmon SC; Tidey JW; Gaalema DE; Hughes JR; Stitzer ML; Durand H; Bunn JY; Priest JS; Arger CA; Miller ME; Bergeria CL; Davis DR; Streck JM; Reed DD; Skelly JM; Tursi L
    JAMA Psychiatry; 2017 Oct; 74(10):1056-1064. PubMed ID: 28832876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential reduction exposure products and FDA tobacco and regulation: a CNS call to action.
    Heath J; Andrews J; Balkstra CR
    Clin Nurse Spec; 2004; 18(1):40-8; quiz 49-50. PubMed ID: 15061445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials methods for evaluation of potential reduced exposure products.
    Hatsukami DK; Hanson K; Briggs A; Parascandola M; Genkinger JM; O'Connor R; Shields PG
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3143-95. PubMed ID: 19959672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
    Proctor RN
    Tob Control; 2016 Sep; 26(5):487-488. PubMed ID: 28831030
    [No Abstract]   [Full Text] [Related]  

  • 20. Population Modeling of Modified Risk Tobacco Products Accounting for Smoking Reduction and Gradual Transitions of Relative Risk.
    Poland B; Teischinger F
    Nicotine Tob Res; 2017 Nov; 19(11):1277-1283. PubMed ID: 28371856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.